IL98999A - 4-Amino-G4 -steroids, a process for their preparation and use as A5-reductase inhibitors - Google Patents

4-Amino-G4 -steroids, a process for their preparation and use as A5-reductase inhibitors

Info

Publication number
IL98999A
IL98999A IL9899991A IL9899991A IL98999A IL 98999 A IL98999 A IL 98999A IL 9899991 A IL9899991 A IL 9899991A IL 9899991 A IL9899991 A IL 9899991A IL 98999 A IL98999 A IL 98999A
Authority
IL
Israel
Prior art keywords
alkyl
hydrogen
amino
double bond
give
Prior art date
Application number
IL9899991A
Other languages
English (en)
Hebrew (he)
Other versions
IL98999A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/671,555 external-priority patent/US5143909A/en
Priority claimed from US07/720,900 external-priority patent/US5120840A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL98999A0 publication Critical patent/IL98999A0/xx
Publication of IL98999A publication Critical patent/IL98999A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL9899991A 1990-08-01 1991-07-29 4-Amino-G4 -steroids, a process for their preparation and use as A5-reductase inhibitors IL98999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56104190A 1990-08-01 1990-08-01
US07/671,555 US5143909A (en) 1991-03-19 1991-03-19 Aminosteroids in a method for inhibiting c17-20 lyase
US07/720,900 US5120840A (en) 1990-08-01 1991-07-02 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors

Publications (2)

Publication Number Publication Date
IL98999A0 IL98999A0 (en) 1992-07-15
IL98999A true IL98999A (en) 1995-10-31

Family

ID=27415841

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9899991A IL98999A (en) 1990-08-01 1991-07-29 4-Amino-G4 -steroids, a process for their preparation and use as A5-reductase inhibitors

Country Status (17)

Country Link
EP (1) EP0469548B1 (ko)
JP (1) JP3021819B2 (ko)
KR (1) KR100186812B1 (ko)
AT (1) ATE138931T1 (ko)
AU (1) AU637247B2 (ko)
CA (1) CA2048242C (ko)
DE (1) DE69119992T2 (ko)
DK (1) DK0469548T3 (ko)
ES (1) ES2090184T3 (ko)
FI (1) FI102377B (ko)
GR (1) GR3020672T3 (ko)
HU (1) HU210046B (ko)
IE (1) IE75198B1 (ko)
IL (1) IL98999A (ko)
NO (1) NO180339C (ko)
NZ (1) NZ239142A (ko)
PT (1) PT98518B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
ATE165368T1 (de) * 1991-12-20 1998-05-15 Glaxo Wellcome Inc Inhibitoren von testosteron-5-alpha reductase.
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5356935A (en) * 1993-12-13 1994-10-18 Eli Lilly And Company Reduced phenanthrenes
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US20100047338A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
CN102686600A (zh) 2009-02-05 2012-09-19 托凯药业股份有限公司 甾体cyp17抑制剂/抗雄激素物质的新型药物前体
EP2968370A4 (en) 2013-03-14 2016-09-21 Univ Maryland AGENT FOR ANDROGEN RECEPTOR DOWNWARD CONTROL AND USES THEREOF
JP2016528252A (ja) 2013-08-12 2016-09-15 トーカイ ファーマシューティカルズ， インコーポレイテッド アンドロゲン標的治療を使用する新生物障害の処置のためのバイオマーカー

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780070A (en) * 1972-09-21 1973-12-18 Schering Corp 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation
CA1154008A (en) * 1979-05-02 1983-09-20 Thomas R. Blohm STEROID 5.alpha.-REDUCTASE INHIBITORS
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives

Also Published As

Publication number Publication date
NO912981D0 (no) 1991-07-31
CA2048242A1 (en) 1992-02-02
IE75198B1 (en) 1997-08-27
HUT59156A (en) 1992-04-28
NO180339B (no) 1996-12-23
JP3021819B2 (ja) 2000-03-15
EP0469548A3 (en) 1992-06-03
KR100186812B1 (ko) 1999-04-01
FI913657A (fi) 1992-02-02
FI102377B1 (fi) 1998-11-30
ES2090184T3 (es) 1996-10-16
AU8136291A (en) 1992-02-06
NO180339C (no) 1997-04-02
EP0469548A2 (en) 1992-02-05
PT98518B (pt) 1999-01-29
FI913657A0 (fi) 1991-07-31
AU637247B2 (en) 1993-05-20
ATE138931T1 (de) 1996-06-15
GR3020672T3 (en) 1996-10-31
NO912981L (no) 1992-02-03
NZ239142A (en) 1994-05-26
JPH06172379A (ja) 1994-06-21
FI102377B (fi) 1998-11-30
DK0469548T3 (da) 1996-06-24
IL98999A0 (en) 1992-07-15
DE69119992D1 (de) 1996-07-11
HU912558D0 (en) 1992-01-28
CA2048242C (en) 2003-04-15
IE912705A1 (en) 1992-02-12
PT98518A (pt) 1992-06-30
EP0469548B1 (en) 1996-06-05
HU210046B (en) 1995-01-30
DE69119992T2 (de) 1997-02-06
KR920004409A (ko) 1992-03-27

Similar Documents

Publication Publication Date Title
US5155107A (en) 17β-substituted-4-aza-5α-androstan-3-one derivatives and process for their preparation
EP0469548B1 (en) 4-Amino-delta4-steroids and their use as 5alpha-reductase inhibitors
US5120840A (en) 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
AU642757B2 (en) 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors
US5318961A (en) 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
HU197919B (en) Process for producing 10beta-alkinylestrene derivatives and pharmaceutical compositions comprising same
US5218110A (en) 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5143909A (en) Aminosteroids in a method for inhibiting c17-20 lyase
US5130424A (en) 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
US5189032A (en) 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
IE861970L (en) Steroidal aromatase inhibitors
KR0184643B1 (ko) 4-아미노-델타4,6-스테로이드 및 5알파-환원효소 억제제로서의 그의 용도
US5457097A (en) Androst-4-eno[4,5-b]pyrrole derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)